Tobacco-specific nitrosamines, NNK and NNN, are carcinogenic in laboratory and are potential human carcinogens. NNN is metabolized to a DNA pyridyloxobutylating agent whereas NNK is metabolized to both DNA pyridyloxobutylating and methylating intermediates. Pyridyloxobutylation of DNA results in the formation of a variety of DNA adducts, one of which is O6-[4-oxo-4-(3-pyridyl)butyl]guanine (O6-pobG). Our previous studies indicate that this mutagenic adduct is repaired by O6-alkylguanine-DNA alkyltransferase (AGT). Human AGT variants differ substantially in their ability to repair O6-pobG, suggesting that individuals with reduced repair capacity may be at increased risk of tobacco-related cancers. However, it is unclear what the overall role O6-pobG makes in the mutagenic and carcinogenic properties of pyridyloxobutylating nitrosamines. The central hypothesis under investigation in this grant is that O6-pobG contributes significantly to the mutagenic and carcinogenic activity of the tobacco-specific nitrosamines, NNK and NNN, when not repaired. We plan to test our central hypothesis by pursuing the following specific aims: 1) Determine if O6-pobG formation and persistence are linked to the pulmonary carcinogenic properties of NNN and NNKOAc in A/J mice. 2) Phenotype human livers for their ability to repair bulky O6-alkylguanine adducts relative to O6-mG adducts by AGT. 3) Determine the involvement of other repair pathways in the overall repair of the mutagenic O6-pobG and determine whether these pathways affect the mutagenic properties of pyridyloxobutylating agents. Collectively, these aims will establish the importance of formation and repair of O6-pobG in the mutagenic and carcinogenic properties of pyridyloxobutylating nitrosamines. These studies will set the stage for a molecular epidemiological study to determine whether individuals who are unable to repair this mutagenic adduct are at increased risk of tobacco-related cancers. ? ?

National Institute of Health (NIH)
National Cancer Institute (NCI)
Research Project (R01)
Project #
Application #
Study Section
Cancer Etiology Study Section (CE)
Program Officer
Poland, Alan P
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
University of Minnesota Twin Cities
Public Health & Prev Medicine
Schools of Public Health
United States
Zip Code
Peterson, Lisa A (2017) Context Matters: Contribution of Specific DNA Adducts to the Genotoxic Properties of the Tobacco-Specific Nitrosamine NNK. Chem Res Toxicol 30:420-433
Peterson, Lisa A; Urban, Anna M; Vu, Choua C et al. (2013) Role of aldehydes in the toxic and mutagenic effects of nitrosamines. Chem Res Toxicol 26:1464-73
Urban, Anna M; Upadhyaya, Pramod; Cao, Qing et al. (2012) Formation and repair of pyridyloxobutyl DNA adducts and their relationship to tumor yield in A/J mice. Chem Res Toxicol 25:2167-78
Li, Li; Perdigao, Joana; Pegg, Anthony E et al. (2009) The influence of repair pathways on the cytotoxicity and mutagenicity induced by the pyridyloxobutylation pathway of tobacco-specific nitrosamines. Chem Res Toxicol 22:1464-72
Sandercock, Linda E; Hahn, Jennifer N; Li, Li et al. (2008) Mgmt deficiency alters the in vivo mutational spectrum of tissues exposed to the tobacco carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK). Carcinogenesis 29:866-74
Peterson, Lisa A; Wagener, Tanja; Sies, Helmut et al. (2007) Decomposition of S-nitrosocysteine via S- to N-transnitrosation. Chem Res Toxicol 20:721-3
Mijal, Renee S; Kanugula, Sreenivas; Vu, Choua C et al. (2006) DNA sequence context affects repair of the tobacco-specific adduct O(6)-[4-Oxo-4-(3-pyridyl)butyl]guanine by human O(6)-alkylguanine-DNA alkyltransferases. Cancer Res 66:4968-74
Choi, Jeong-Yun; Chowdhury, Goutam; Zang, Hong et al. (2006) Translesion synthesis across O6-alkylguanine DNA adducts by recombinant human DNA polymerases. J Biol Chem 281:38244-56